4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-045397
Chief Business Development Off sold 7,187 shares at $40.00 ($287,480)
- Chief Business Development Off acquired 7,187 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BENZENO SHARON Chief Business Development Off | 2020-08-04 | Option exercise | +2,604 | $6.55 | $17,056 | 2,604 | D |
| BENZENO SHARON Chief Business Development Off | 2020-08-04 | Option exercise | +2,604 | $6.55 | $17,056 | 5,208 | D |
| BENZENO SHARON Chief Business Development Off | 2020-08-04 | Option exercise | +1,562 | $7.27 | $11,356 | 6,770 | D |
| BENZENO SHARON Chief Business Development Off | 2020-08-04 | Option exercise | +417 | $6.32 | $2,635 | 7,187 | D |
| BENZENO SHARON Chief Business Development Off | 2020-08-04 | Sale | −7,187 | $40.00 | $287,480 | 0 | D |
| Derivatives | |||||||
| BENZENO SHARON Chief Business Development Off | 2020-08-04 | Option exercise · Stock Option (Right to Buy) | −2,604 | 39,063 | D | ||
| BENZENO SHARON Chief Business Development Off | 2020-08-04 | Option exercise · Stock Option (Right to Buy) | −2,604 | 67,709 | D | ||
| BENZENO SHARON Chief Business Development Off | 2020-08-04 | Option exercise · Common Stock (Right to Buy) | −1,562 | 45,313 | D | ||
| BENZENO SHARON Chief Business Development Off | 2020-08-04 | Option exercise · Common Stock | −417 | 0 | D | ||
| Open-market sales · 7,187 sh · avg $40.00 · $287,480 | |||||||
Loading xslF345X03/doc4.xml…